BioMarin Highlights Impressive Second Quarter 2025 Earnings and Plans Ahead for Growth BioMarin Pharmaceutical Inc. reports significant revenue growth in Q2 2025, raising full-year guidance. New therapies and acquisitions contribute to strong pipeline progress.

BioMarin Highlights Impressive Second Quarter 2025 Earnings and Plans Ahead for Growth #USA #San_Rafael #BioMarin #VOXZOGO #BMN_333